Heron Therapeutics (NASDAQ: HRTX) EVP logs RSU vesting and tax withholding
Rhea-AI Filing Summary
Heron Therapeutics executive William P. Forbes, EVP and Chief Development Officer, reported equity compensation activity on July 19, 2026. He exercised 3874 restricted stock units into common stock, and 1101 shares of common stock were disposed of in a tax-withholding transaction at $0.47 per share. Following these transactions, he directly owned 225485 shares of common stock and held 23246 restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,773 shares
Net Buy
3 txns
Insider
Forbes William P
Role
EVP, Chief Development Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F2 | 3,874 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 3,874 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 1,101 | $0.47 | $517.47 |
Holdings After Transaction:
Restricted Stock Units — 23,246 shares (Direct);
Common Stock — 224,384 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).
Key Figures
Common shares acquired via RSU conversion: 3874 shares
Shares withheld for taxes: 1101 shares at $0.47 per share
Direct common shares after transactions: 225485 shares
+1 more
4 metrics
Common shares acquired via RSU conversion
3874 shares
Exercise of restricted stock units into common stock on July 19, 2026
Shares withheld for taxes
1101 shares at $0.47 per share
Tax-withholding disposition of common stock on July 19, 2026
Direct common shares after transactions
225485 shares
Direct ownership of Heron Therapeutics common stock following the reported Form 4 transactions
Restricted stock units outstanding
23246 units
Restricted stock units remaining after 3874 units were exercised into common stock
Key Terms
Restricted Stock Units, tax-withholding disposition, derivative security
3 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"transaction_action is described as a tax-withholding disposition of common stock."
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did HRTX executive William P. Forbes report on July 19, 2026?
William P. Forbes reported equity compensation activity, including 3874 restricted stock units converting into common stock and a tax-withholding disposition of 1101 shares at $0.47 per share. After these transactions, he directly owned 225485 Heron Therapeutics common shares and retained additional RSUs.
What are William P. Forbes' HRTX holdings after the reported transactions?
Following the July 19, 2026 transactions, William P. Forbes directly owned 225485 shares of Heron Therapeutics common stock and held 23246 restricted stock units. The RSUs remain outstanding as derivative equity awards that may convert into additional common shares upon future vesting.
Were William P. Forbes' HRTX transactions made under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and no footnote describes a trading plan. This means the reported RSU conversion and tax-withholding disposition were not identified as occurring under a pre-arranged Rule 10b5-1 trading plan.